- A serotonin–norepinephrine–dopamine
reuptake inhibitor (
SNDRI), also
known as a
triple reuptake inhibitor (TRI), is a type of drug that acts as a combined...
- Mcn 5707 is a
SNDRI agent designated for the
treatment of depression. It was
developed by
Bruce Maryanoff of
McNeil (now
Johnson & Johnson) in the 1980s...
- Consequently,
amphetamine is
usually classified as an NDRI
instead of an
SNDRI. However, the
substituted amphetamines have a very
diverse effects profile...
- of
activity (serotonin-noradrenaline and dopamine) (c.f.
SNDRI). For
another related SNDRI agent see PC71812205. The
racemic agent had IC50's of 11,...
-
administration Topical, by mouth, insufflation, intravenous,
inhalation Drug
class SNDRI; Stimulant;
Local anesthetic ATC code N01BC01 (WHO) R02AD03 (WHO), S01HA01...
-
reuptake inhibitor (
SNDRI) and was
developed by Luye
Pharma Group.
Toludesvenlafaxine is
described as an
SNDRI and
prodrug to desvenlafaxine...
-
receptors and weak serotonin–norepinephrine–dopamine
reuptake inhibitor (
SNDRI).
Nefazodone was
introduced for
medical use in 1994.
Generic versions were...
- Serotonin-norepinephrine
reuptake inhibitor (SNRI) Norepinephrine-dopamine
reuptake inhibitor (NDRI) Serotonin-norepinephrine-dopamine
reuptake inhibitor (
SNDRI)...
- Serotonin-norepinephrine
reuptake inhibitor (SNRI) Norepinephrine-dopamine
reuptake inhibitor (NDRI) Serotonin-norepinephrine-dopamine
reuptake inhibitor (
SNDRI)...
- make
cocaethylene a serotonin-norepinephrine-dopamine
reuptake inhibitor (
SNDRI; also
known as a "triple
reuptake inhibitor"). In most users, cocaethylene...
